Analysis of the cardiac stimulant properties of (3,4-dihydroxyphenyl)-cyclopropylamine (ASL-7003) and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (A6,7DTN).
D000818:Animals; D003521:Cyclopropanes / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D006168:Guinea Pigs; D006220:Haloperidol / Q000494:pharmacology; D006321:Heart / Q000187:drug effects* / Q000294:innervation; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D009284:Naphthols / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D013764:Tetrahydronaphthalenes / Q000494:pharmacology
D003521:Cyclopropanes; D009284:Naphthols; D011943:Receptors, Adrenergic, beta; D013764:Tetrahydronaphthalenes; D006220:Haloperidol; D003891:Desipramine; D004298:Dopamine; D010646:Phentolamine